Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer.

Konstantin Schlick (First author), Steiner Markus, Florian Huemer (Co-author), Lukas Ratzinger, Nadja Zaborsky (Co-author), Hufnagl Clemens, Daniel Neureiter (Co-author), Bettina Neumayer (Co-author), Alinger-Scharinger Beate, Steiner Florian, Varga Martin, Michael Grundbichler (Co-author), Lukas Weiss (Co-author), Thomas Melchardt (Co-author), Richard Greil (Co-author), Alexander Egle* (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

7 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1466-1471
JournalPANCREATOLOGY
Volume21
Issue number8
DOIs
Publication statusPublished - 2021

Keywords

  • PROGNOSTIC VALUE
  • PLASMA
  • DNA

Cite this